A Study of JNJ-79635322 in Combination With Daratumumab or Pomalidomide for Multiple Myeloma
NCT 06768489 Brief Summary The primary purpose of this study for Part…
Read more arrow_forwardNCT 06768489 Brief Summary The primary purpose of this study for Part…
Read more arrow_forwardNCT 06139406 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 04419649 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 06478693 Brief Summary This is a multicenter, open-label, Phase 1,…
Read more arrow_forwardNCT 05947851 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardNCT 06792695 Brief Summary The main purpose of this study is to…
Read more arrow_forwardNCT 05384626 Brief Summary Phase 1/2, dose escalation and expansion study designed…
Read more arrow_forwardNCT 06640361 Brief Summary An international multicenter, open, single-arm pivotal registration phase…
Read more arrow_forwardNCT 03899792 Brief Summary This is an open-label, multi-center Phase 1/2 study…
Read more arrow_forwardNCT 05245968 Brief Summary This study consists of Dose escalation part…
Read more arrow_forward